Errata: Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM)

156 閲覧数

DOI:

10.3791/5755

未公開

この記事について

サマリー

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM).

要約

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated.

プロトコル

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated from:

David Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. PeriRx LLC sublicensed intellectual properties pertaining to molecular diagnostics from RNAmeTRIX. David Wong is a consultant to PeriRx.

to

David T. Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. He holds equity in RNAmeTRIX, and serves as a company director and scientific advisor. The University of California also holds equity in RNAmeTRIX. Intellectual property that David T. Wong invented and which was patented by the University of California has been licensed to RNAmeTRIX. Additionally, he is a paid consultant to PeriRx.

開示事項

No conflicts of interest declared.

再版と許可

このJoVE記事のテキストまたは図の再利用許可をリクエスト

許可をリクエスト

タグ